Kindly Md, INC Form 4 insider transactions

Kindly MD Director Mark W. Yusko acquired 112,781 shares of common stock through restricted stock units, increasing his beneficial ownership to 2,212,781 shares.
Kindly MD, Inc. Director Perianne Boring McNulty was granted 112,781 restricted stock units, vesting in August 2026.
Kindly MD, Inc. Director Charles Phillip Blackburn was granted 112,781 restricted stock units, vesting in August 2026.
Kindly MD's Chief Investment Officer, Tyler Matthew Evans, acquired 2,232,114 shares of common stock, increasing his beneficial ownership.
Kindly MD's Chief Compliance Officer, Andrew Creighton, acquired over 2.2 million shares of common stock at no cost, increasing his beneficial ownership.
Kindly MD, Inc.'s CEO, David F. Bailey, reported the acquisition of over 11 million shares of common stock.
Director Christian S. Robinson reports acquisition of common stock and options in Kindly MD, Inc.
Director Gary Seelhorst reports acquisition and disposal of Kindly MD, Inc. stock and options.
Director Amy Powell reports transactions involving Kindly MD, Inc. shares and options, including acquisition of common stock for services and options vesting upon a change in control.
Kindly MD, Inc. CEO Timothy Pickett reports acquisition of common stock and options, signaling potential confidence in the company's future.
Jared Barrera, CFO of Kindly MD, Inc., reports the acquisition of 35,000 options with an exercise price of $3.90.
Adam Cox, COO of Kindly MD, Inc., reports the acquisition of 40,000 options exercisable for common stock.
Director Amy Powell reports the acquisition and disposal of Kindly MD, Inc. common stock on October 24, 2024.
Director Christian S. Robinson reported acquiring and disposing of 837 shares of Kindly MD, Inc. common stock on October 24, 2024.
Gary Seelhorst, a director of Kindly MD, Inc., reported acquiring 837 shares of common stock at $1.05 per share on October 24, 2024.
Adam Cox, COO of Kindly MD, Inc., reports the acquisition of 9,000 shares of common stock at a price of $1.05 per share.